WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Perioperative Cognitive Training in Thoracic Surgery

Not Applicable

Withdrawn

Conditions: Cognitive Function Abnormal
Lung Cancer
Pain, Postoperative

Interventions: Behavioral: COFLEX neurocognitive training
Behavioral: Crossword puzzles

First Posted Date: 2020-09-24

Last Posted Date: 2023-01-30

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT04563234

Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers

Not Applicable

Completed

Conditions: Sarcoma
Thoracic Cancer
Abdominal Cancer
Pelvic Cancer

Interventions: Radiation: Stereotactic body radiotherapy
Procedure: Research blood draw

First Posted Date: 2020-09-17

Last Posted Date: 2024-08-29

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 70

Registration Number: NCT04553471

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma

Phase 2

Active, not recruiting

Conditions: Metastatic Soft-tissue Sarcoma

Interventions: Drug: Cabozantinib
Drug: Nivolumab
Drug: Ipilimumab

First Posted Date: 2020-09-16

Last Posted Date: 2024-06-10

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 105

Registration Number: NCT04551430

Locations: 🇺🇸
Stanford University Medical Center, Stanford, California, United States
🇺🇸
Abramson Cancer Center at Pennsylvania Hospital, Philadelphia, Pennsylvania, United States
🇺🇸
University of Colorado, Aurora, Colorado, United States

and more 1 locations

Management of Post-Tonsillectomy Pain in Pediatric Patients

Phase 3

Completed

Conditions: Pain, Postoperative
Tonsillar Hypertrophy
Tonsillitis

Interventions: Drug: Combined Acetaminophen and Ibuprofen
Drug: Alternating Acetaminophen and Ibuprofen

First Posted Date: 2020-09-16

Last Posted Date: 2024-07-11

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 50

Registration Number: NCT04551196

Locations: 🇺🇸
Saint Louis Children's Hospital, Saint Louis, Missouri, United States

Fostamatinib as a Single Agent or in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis With Severe Thrombocytopenia

Phase 2

Terminated

Conditions: Myelofibrosis
Thrombocytopenia

Interventions: Drug: Fostamatinib
Drug: Ruxolitinib

First Posted Date: 2020-09-10

Last Posted Date: 2023-12-15

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 3

Registration Number: NCT04543279

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition

Phase 1

Completed

Conditions: Pancreas Cancer
Pancreatic Cancer
Cancer of the Pancreas

Interventions: Drug: Dapagliflozin
Device: BIOSENSE meters

First Posted Date: 2020-09-09

Last Posted Date: 2023-02-14

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 15

Registration Number: NCT04542291

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

PET Detection of CCR2 in Human Atherosclerosis

Phase 1

Recruiting

Conditions: Carotid Atherosclerosis

Interventions: Drug: Group 1-64CU-DOTA-ECL1i (radioactive imaging medicine)
Drug: Group 2 64CU-DOTA-ECL1i (radioactive imaging medicine)

First Posted Date: 2020-09-03

Last Posted Date: 2023-12-05

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 100

Registration Number: NCT04537403

Locations: 🇺🇸
Washington University CCIR, Saint Louis, Missouri, United States

Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients

Phase 2

Terminated

Conditions: Pancreatic Cancer
Cancer of the Pancreas
Pancreas Cancer

Interventions: Drug: CDX-1140
Drug: CDX-301
Procedure: Research blood draw

First Posted Date: 2020-09-02

Last Posted Date: 2024-10-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 16

Registration Number: NCT04536077

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

PREVENT Tool Study: Late Effects Clinic

Not Applicable

Completed

Conditions: Cardiovascular Disease
Childhood Obesity

Interventions: Other: PREVENT Tool
Other: Wait-List Control

First Posted Date: 2020-08-28

Last Posted Date: 2023-04-25

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 65

Registration Number: NCT04530825

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

F-18 Rhodamine 6G PET Imaging for Myocardial Blood Flow

Early Phase 1

Suspended

Conditions: Coronary Artery Disease

Interventions: Drug: Rhodamine 6G

First Posted Date: 2020-08-27

Last Posted Date: 2022-08-24

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 15

Registration Number: NCT04528758

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy